Equities

Option Care Health Inc

Option Care Health Inc

Actions
  • Price (USD)3.27
  • Today's Change-0.03 / -0.91%
  • Shares traded683.82k
  • 1 Year change-17.84%
  • Beta0.4468
Data delayed at least 15 minutes, as of Dec 13 2019 21:00 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Option Care Health, Inc., formerly BioScrip, Inc., incorporated on March 22, 1996, provides home and alternate site infusion services in the United States. The Company provides a range of infusion therapies to patients. It provides care for patients with acute and chronic conditions. Its therapeutic services include anti-infective, Option Care Women’s health, bleeding disorders, heart failure, immunoglobulin, nutrition support, chronic inflammatory disorders and specialized therapies. Its other services include hemophilia care, transplant and pediatrics.

  • Revenue in USD (TTM)1.77bn
  • Net income in USD-78.43m
  • Incorporated1996
  • Employees1.66k
  • Location
    Option Care Health Inc3000 Lakeside Dr Ste 300NBANNOCKBURN 60015-5405United StatesUSA
  • Phone+1 (312) 940-2443
  • Fax+1 (800) 253-5177
  • Websitehttps://www.bioscrip.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BIOS:NAQ since
announced
Transaction
value
Option Care Enterprises IncDeal completed15 Mar 201915 Mar 2019Deal completed-6.30%2.82bn
Data delayed at least 15 minutes, as of Dec 13 2019 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CorVel Corporation594.28m47.85m1.51bn3.90k32.617.5719.582.552.542.5731.5310.941.61--8.71152,222.1012.9913.6919.6021.4621.5320.288.056.19----0.00--6.704.4741.536.05-3.60--
BioTelemetry Inc430.68m38.66m1.51bn1.50k41.924.2019.153.521.061.0611.8510.620.688921.409.24287,117.306.186.406.797.3962.3060.698.986.762.356.900.35250.0039.3025.27641.48--24.70--
Irhythm Technologies Inc199.66m-52.81m1.69bn748.00--11.06--8.48-2.14-2.148.095.800.929116.808.66266,921.10-24.58-34.82-29.11-41.7075.5269.42-26.45-37.324.07-27.550.1952--49.5257.15-64.11--62.87--
Senior Housing Properties Trust1.07bn-155.08m1.74bn600.00--0.616812.281.63-0.6528-0.65284.5011.870.1488----1,782,230.00-2.082.59-2.142.6355.1261.38-14.0017.09--0.82380.5519205.723.957.9794.349.32-1.020.00
Magellan Health Inc7.20bn7.69m1.89bn10.50k290.561.3813.340.2620.26540.2514292.8355.682.33152.128.68685,848.700.24832.560.3583.862.404.250.10671.161.652.360.3390.0025.2715.58-75.97-27.831.13--
Progyny Inc-100.00bn-100.00bn2.18bn137.00--------------1.59----------------------------0.00--116.94--15.99------
The Ensign Group, Inc.2.26bn109.50m2.29bn23.46k21.893.3814.041.011.961.9640.5612.721.29--7.9596,455.996.336.487.728.3219.2412.914.903.54--12.370.282214.7610.3517.67108.0729.0136.356.72
MEDNAX Inc3.54bn-1.12bn2.31bn7.63k--1.56--0.6518-13.69-17.4741.6717.570.6991--6.96464,375.50-22.176.28-24.436.93-----31.719.65--3.870.5673--5.4611.117.29-0.862325.57--
Option Care Health Inc1.77bn-78.43m2.31bn1.66k--2.50--1.30-0.2364-0.23634.631.311.1220.767.881,070,130.00-4.78-20.26-5.50-25.6022.5329.43-4.26-15.421.36-0.22110.5788---13.250.354455.49---11.53--
Livongo Health Inc140.81m-61.60m2.45bn576.00--4.88--17.38-0.6775-0.67751.555.31------365,742.80--------70.09---43.59--10.98--0.00--121.82---97.31------
Agape ATP Corp1.37m-481.83k2.48bn----554.46--1,816.12-0.0013-0.00130.00360.01190.2705--4.26---9.53---10.21--7.22---35.24-----7.780.00--217.46---298.89------
HMS Holdings Corp618.78m103.27m2.59bn2.50k25.143.1016.514.181.171.177.009.470.5615--3.09247,511.209.373.4210.123.7935.1429.4316.696.18----0.22430.0014.794.00120.636.573.36--
NeoGenomics, Inc.378.44m2.06m2.76bn1.50k1,507.135.54122.617.290.01750.01753.774.770.64919.984.92252,291.300.3538-0.59870.3928-0.680748.6344.010.5451-0.88724.054.400.1799--15.1933.01143.6624.5348.06--
Acadia Healthcare Company Inc3.07bn-201.36m2.84bn28.60k--1.16--0.9253-2.31-2.4235.0127.620.4632--8.83107,369.80-3.030.893-3.260.9566-----6.551.771.162.080.5680.006.2133.39-198.06--36.11--
Select Medical Holdings Corporation5.34bn136.35m3.05bn33.70k21.664.067.620.56981.051.0540.965.580.8137--6.92158,576.302.853.293.904.2514.6914.343.503.50--2.470.643211.2816.4011.3033.393.5517.83--
Myokardia Inc12.40m-233.12m3.08bn220.00--6.82--248.65-5.22-5.220.28689.790.0269----75,151.52-50.54-20.49-55.91-24.65-645.16---1,880.02-163.29----0.00--193.29---18.75--23.61--
Data as of Dec 13 2019. Currency figures normalised to Option Care Health Inc's reporting currency: US Dollar USD

Institutional shareholders

10.66%Per cent of shares held by top holders
HolderShares% Held
Gilder, Gagnon, Howe & Co. LLCas of 30 Sep 201915.65m2.22%
Venor Capital Management LPas of 30 Sep 201911.57m1.64%
Ares Management LLCas of 30 Sep 20199.47m1.34%
The Vanguard Group, Inc.as of 30 Sep 20199.19m1.30%
BlackRock Fund Advisorsas of 30 Sep 20198.44m1.20%
Rothschild & Co. Asset Management US, Inc.as of 30 Sep 20195.93m0.84%
Gabelli Funds LLCas of 30 Sep 20195.82m0.83%
FIAM LLCas of 30 Sep 20193.65m0.52%
DWS Investment Management Americas, Inc.as of 30 Sep 20192.92m0.41%
Royce & Associates LPas of 30 Sep 20192.58m0.37%
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.